RNA Biology of Fungal Infections

Schwarz C, Eschenhagen P, Schmidt H, Hohnstein T, Iwert C, Grehn C, Roehmel J, Steinke E, Stahl M, Lozza L, Tikhonova E, Rosati E, Stervbo U, Babel N, Mainz JG, Wisplinghoff H, Ebel F, Jia LJ, Blango MG, Hortschansky P, Brunke S, Hube B, Brakhage AA, Kniemeyer O, Scheffold A, Bacher P (2023) Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosis. J Clin Invest , e161593.

Fleming BA^*, Blango MG^*, Rousek AA^*, Kincannon WM, Tran A, Lewis AJ, Russell CW, Zhou Q, Baird LM, Barber AE, Brannon JR, Beebout CJ, Bandarian V, Hadjifrangiskou M, Howard MT, Mulvey MA (2022) A tRNA modifying enzyme as a tunable regulatory nexus for bacterial stress responses and virulence. Nucleic Acids Res 50(13), 7570-7590.

Halder LD, Babych S, Palme DI, Mansouri-Ghahnavieh E, Ivanov L, Ashonibare V, Langenhorst D, Prusty B, Rambach G, Wich M, Trinks N, Blango MG, Kornitzer D, Terpitz U, Speth C, Jungnickel B, Beyersdorf N, Zipfel PF, Brakhage AA, Skerka C (2022) Candida albicans induces cross-kingdom miRNA trafficking in human monocytes to promote fungal growth. mBio 13(1), e0356321.

Rafiq M, Rivieccio F, Zimmermann AK, Visser C, Bruch A, Krüger T, González Rojas K, Kniemeyer O, Blango MG, Brakhage AA (2022) PLB-985 neutrophil-like cells as a model to study Aspergillus fumigatus pathogenesis. mSphere 7(1), e0094021.

Brakhage AA, Zimmermann AK, Rivieccio F, Visser C, Blango MG (2021) Host-derived extracellular vesicles for antimicrobial defense. microLife 2, uqab003. (Review)

Bruch A^*, Kelani AA^*, Blango MG^# (2021) RNA-based therapeutics to treat human fungal infections. Trends Microbiol 30(5), 411-420. (Review)